This is a working overview of research peptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-02 and is reviewed periodically as new material appears.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid as supplied |
| Water solubility | Soluble | Dissolves in aqueous media |
| Typical storage temperature | -20 °C | Dry powder, desiccated, protected from light |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity from peak area; mass for identity |
| Common synonyms | Tβ4 fragment; thymosin beta-4 fragment | Naming varies by supplier and catalogue |
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
== Post-parliamentary career (2024–present) == In June 2025, Galloway renounced his opposition to Scottish independence, saying that he would now be in favour of a second referendum. Writing on X, he said: “We support the right of the Scots to self-determination. Eleven years after they last did so we believe the time for another referendum is close. Given the collapsing authority of the British state, the pitiful prime minister Starmer and the moral decline of British society, the result cannot easily be predicted. Britain has become a cesspit." This followed a comment Galloway had made on X in September 2024, in which he said: "You COULD persuade me to Scottish Independence, you could never persuade me to the SNP." In August 2025, Galloway announced that he would be contesting the 2026 Scottish Parliament election as the Workers Party candidate for Glasgow Southside. Additionally, he said that he would be second on the party list for the Glasgow region. In a press conference shortly after his election as MP for Rochdale in February 2024, Galloway had said that he was "no longer involved in Scottish politics", though did mention his support of the SNP's stance on Gaza, adding that they had been “outstanding on the Gaza question, at least by comparison with the two big parties of the state”. In light of this, he revealed that friend and lead candidate for Glasgow, Yvonne Ridley, had persuaded him to stand.
On 27 March 2022, the Legislative Assembly declared a 30-day state of emergency, formally known as a "state of exception" ("régimen de excepción") and sometimes known as the "war on gangs". The state of emergency suspended constitutional rights that included freedom of assembly, freedom of association, the right to privacy in communication, the right to be informed of the reason for arrest, the right to remain silent, and the right to legal representation. The requirement for any arrested individual to see a judge within 72 hours of arrest was also suspended. The military was mobilized in neighborhoods controlled by gangs in an effort to reassert government control, and made large-scale arrests of suspected gang members across the country. On several occasions, Bukele ordered security forces to blockade certain municipalities to capture all gang members within them. By October 2024, blockades were implemented twice in Apopa, Cabañas, Comasagua, Nuevo Concepción, San Marcos, southern Chalatenango, and Soyapango.
He mostly appears during radio transmissions while guiding Alyx and Gordon to White Forest, and argues bitterly with Magnusson, whom Vance states was Kleiner's rival for grant money at Black Mesa. Upon the discovery of the Borealis in Judith Mossman's decoded message, Kleiner expresses a wish to use the technology residing in the ship against the Combine, opposing Eli's vehement desire to destroy it in order to prevent "another Black Mesa".
Sources: en.wikipedia.org
=== Bev Harris === Beverly Lorraine "Bev" Harris is played by Estelle Parsons. Beverly is the mother of Roseanne and Jackie, the wife of Al, and the daughter of Nana Mary. She has a half-sister named Sonya. Overbearing, critical, and shrill, she annoys her family members. She often nags them with a high-pitched whiny voice, often with good intentions but presenting them in an inappropriate manner. The family (especially Jackie) avoids spending time with Bev, and she is quick to inadvertently criticize how people run their lives. After the family plays back-and-forth tricks on each other in one Halloween episode, Roseanne ultimately prevails by faking a phone conversation in front of frantic Dan, pretending that Bev is coming for a three-week visit. Bev is traditional and conservative, as opposed to her daughters' more liberal and feminist philosophies. She is generous with the money she receives from her divorce settlement, often giving financial gifts to the family or to bail them out. She provides the seed money for Roseanne and Jackie's business venture, the Lanford Lunch Box, and later provides additional funding as a fourth partner. She is later forced into becoming a silent partner when Roseanne and Jackie are unable to work harmoniously with her. As revenge, Bev sells her share of the restaurant to Roseanne's disliked ex-boss, Leon Carp, making him their new partner.
== Biography == Kyle Kevin Biggar was born in 1986 in Summerside, Prince Edward Island. Biggar studied Biology and Chemistry at St. Francis Xavier University (B.Sc) in Antigonish, Nova-Scotia, Canada, and Biology and Biochemistry at Carleton University (Ph.D 2013). His doctoral research focused on the biochemistry of physiological stress response. The well-known Canadian biochemist Kenneth B. Storey was his thesis advisor during his graduate studies at Carleton University. After completing a post-doctoral fellowship at the University of Western Ontario Schulich School of Medicine and Dentistry, Biggar came back to his alma mater to become an assistant professor of Biochemistry as of 2016.
== Tolerance and overdoses == Fatal opioid overdose typically occurs due to bradypnea, hypoxemia, and decreased cardiac output (hypotension occurs due to vasodilation, and bradycardia further contributes to decreased cardiac output). A potentiation effect occurs when opioids are combined with ethanol, benzodiazepines, barbiturates, or other central depressants which can result in rapid loss of consciousness and an increased risk of fatal overdose. Substantial tolerance to respiratory depression develops quickly, and tolerant individuals can withstand larger doses. However, tolerance to respiratory depression is quickly lost during withdrawal and may be completely reversed within a week. Many overdoses occur in people who return to their previous dose after having lost their tolerance following cessation of opioids. This puts addicts who receive medical treatment for opioid addiction at great risk of overdose when they are released, as they may be particularly vulnerable to relapse. Less commonly, massive overdoses have been known to cause circulatory collapse from vasodilation and bradycardia. Opioid overdoses can be rapidly reversed through the use of opioid antagonists, naloxone being the most widely used example. Opioid antagonists work by binding competitively to μ-opioid receptors and displacing opioid agonists. Additional doses of naloxone may be necessary and supportive care should be given to prevent hypoxic brain injury by monitoring vital signs.
=== 17 April === Russian opposition activist Vladimir Kara-Murza was sentenced to twenty-five years imprisonment for treason and discrediting the Russian military. Slovakia banned the import of grain from Ukraine, following a similar decision by Poland and Hungary on 15 April. Russian President Vladimir Putin visited military commanders in the Russian-occupied part of the Kherson Oblast and troops in Luhansk. In Luhansk he gave soldiers "copies of icons as a gift" for Russian Orthodox Easter which was 16 April. Although Kremlin spokesman Dmitry Peskov said the visit was 17 April, President Putin was heard saying Easter is "coming up". Subsequently, this was edited from the footage of the visit. While Ukrainian forces were training in Europe a Leopard 2A4 was damaged, with the turret being completely dislodged from the hull. The crew were reported as being fine. The accident was believed to be due to crew error or the age of the tank. Slovakia finished its delivery of 13 MiG-29 fighter jets to Ukraine.
Sources: en.wikipedia.org
== Science == Analytic network process, a mathematical decision making technique similar to Analytic Hierarchy Process Atrial natriuretic peptide, a peptide hormone Acyclic nucleoside phosphonate, a group of antiviral drugs Acidic leucine-rich nuclear phosphoprotein 32 family member A ANP32B ANP32C ANP32D ANP32E
12 July – Members of the NASUWT teaching union in England vote to stage strike action over pay, with 85.5% of members voting to do so on a 51.9% turnout. 13 July – Data released by NHS England indicates that 7.47 million people were waiting to begin routing hospital treatment in June 2023, an increase from 7.42 million in May. The UK government proposes a 6.5% pay rise for teachers, with the leaders of all four major teaching unions expressing support for the increase, meaning strikes by teachers in England are likely to end. Pradjeet Veadhasa, 17, and Sukhman Shergill, 17, are sentenced to life imprisonment with minimum terms of 18 and 16 years respectively for the June 2022 murder of 16-year-old Ronan Kanda in Wolverhampton, who they stabbed after mistaking him for an enemy. 14 July – The UK Health Security Agency warns that tens of thousands of cases of measles could potentially occur in London because of low vaccination numbers there. A 65-year-old man is charged with the murders of Naomi Hunte, who was stabbed to death in February 2022, and Fiona Holm, who disappeared in June 2023 and whose body has not been found. The UK government approves plans to build a road tunnel near Stonehenge. Following trial and conviction at Portsmouth Crown Court, Sarah Somerton-How and her lover, George Webb, are both sentenced to 11 years imprisonment for wilful neglect and holding a person in slavery or servitude after they kept Somerton-How's husband, who has cerebral palsy and is severely sight impaired, a prisoner in squalid conditions for four years.
He was one of those vigorous, fearless thinkers who seem to be entirely free from the inhibitions which restrain most of us in narrow paths of scientific enquiry. ... His magnificent courage and imagination led him into every aspect of biology which presented problems to his consciousness. ... His originality of mind made him a stimulating colleague, and to his students he was as gracious as he was inspiring. ... Robertson's main service to science was in the realm of ideas. His practical work was of lesser significance, but in almost every direction in which his imagination led him he either contributed new conceptions or reoriented prevailing ideas." Hardolph Wasteneys, Professor of Biochemistry at the University of Toronto, The Biochemical Journal. A memorial collection of 12 Robertson items — comprised of ten of his previously published articles and the text of two of his speeches — with an introduction (SP.3) by his University of Adelaide colleague, Stuart Wortley Pennycuick (1887–1966) D.Sc., B.Sc., and edited by his wife (Jane Winifred Robertson), The Spirit of Research (BR.66), was published in 1931. On 5 September 1931, in the university's Animal Nutrition Building, Sir George Murray, the Chancellor of the University of Adelaide unveiled a bas-relief commemorative plaque (UA.3), designed and executed by Arthur Murch, that was dedicated to Robertson's memory.
The National Economic Council (NEC) in Pakistan is a constitutional entity tasked with evaluating the nation's economic state and devising strategies to promote equitable development and regional balance. Functioning within the framework of Article 156 of the Constitution of Pakistan, it plays a vital advisory role to both federal and provincial governments on matters pertaining to finance, commerce, social welfare, and economic policies.
Ferroptosis (also known as oxytosis) is a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides. Ferroptosis is biochemically, genetically, and morphologically distinct from other forms of regulated cell death such as apoptosis and necroptosis. Ferroptosis can be initiated by the failure of the glutathione-dependent antioxidant defenses, resulting in unchecked lipid peroxidation and eventual cell death. Lipophilic antioxidants and iron chelators can prevent ferroptotic cell death. Researchers have identified roles in which ferroptosis can contribute to the medical field, such as the development of cancer therapies. Ferroptosis activation plays a regulatory role on growth of tumor cells in the human body. However, the positive effects of ferroptosis could be potentially neutralized by its disruption of metabolic pathways and disruption of homeostasis in the human body. Since ferroptosis is a form of regulated cell death, some of the molecules that regulate ferroptosis are involved in metabolic pathways that regulate cysteine exploitation, glutathione state, nicotinamide adenine dinucleotide phosphate (NADP) function, lipid peroxidation, and iron homeostasis.
Sources: en.wikipedia.org
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.
The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.
Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.